Puerto Rico Pharmaceuticals and Healthcare Report Q4 2016

Date: September 21, 2016
Pages: 91
US$ 1,295.00
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P7218501AC8EN

Download PDF Leaflet

Includes 3 FREE quarterly updates

BMI View: An expected increase in US government funding to strengthen Puerto Rico's healthcare system will support pharmaceutical and healthcare sector growth in the commonwealth over the next few years. While the US administration will continue to seek legislative removal of Puerto Rico's Medicaid funding limitations over the coming months, the increasing risk posed by the Zika virus outbreak in the territory will push for a rise in healthcare funding to become a priority. That said, market growth rates in several segments, including pharmaceuticals, are set to face headwinds due to Puerto Rico's economic recession.

Headline Expenditure Projections
  • Pharmaceuticals: USD3.81bn in 2015 to USD3.82bn in 2016; +0.2%. Forecast in line with last quarter.
  • Healthcare: USD8.06bn in 2015 to USD8.37bn in 2016; +3.8%. Forecast broadly in line with last quarter.
Risk/Reward Index

In Q416, we have revised upwards Puerto Rico's Risk/Reward Index score to 65.7 from 64.5 in the last quarter (out of 100). The score revision was driven by an improvement in the Industry Rewards index. Puerto Rico continues to stand as the third most attractive market to pharmaceutical investors in the Americas region, behind the US and Canada. Puerto Rico's score is driven by high spending per capita on medicine and high patent respect and business environment scores, but dragged down by a small market size and low sector value growth.

Latest Updates

In August 2016, Inovio Pharmaceuticals initiated a trial of its preventative Zika vaccine, GLS-5700, in Puerto Rico. Inovio, which is developing GLS-5700 in collaboration with GeneOne Life Science and academic collaborators from the US and Canada, commenced the first FDA-approved human trial of a Zika vaccine in June 2016.
BMI Industry View
  Table: Headline Pharmaceuticals & Healthcare Forecasts (Puerto Rico 2014-2020)
Industry Forecast
Pharmaceutical Market Forecast
  Table: Pharmaceutical Sales, Historical Data And Forecasts (Puerto Rico 2012-2020)
Healthcare Market Forecast
  Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Puerto Rico 2012-2020)
Prescription Drug Market Forecast
  Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020)
Patented Drug Market Forecast
  Table: Patented Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020)
Generic Drug Market Forecast
  Table: Generic Drug Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020)
OTC Medicine Market Forecast
  Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Puerto Rico 2012-2020)
Pharmaceutical Trade Forecast
  Table: Pharmaceutical Trade Data And Forecasts (Puerto Rico 2014-2020)
Pharmaceuticals & Healthcare Risk/Reward Index
Americas Risk/Reward Index
Puerto Rico Risk/Reward Index
Regulatory Review
  Table: Incentives, Benefits And Discounts For Pharmaceutical Manufacturers
Pricing Regime
Reimbursement Regime
Market Overview
Healthcare Sector
Research & Development
Clinical Trials
Competitive Landscape
Research-Based Industry
  Table: Major International Drugmakers In Puerto Rico
  Table: Puerto Rico - Multinationals' Operations
  Table: Multinational Company Activity, 2015
Generic Drugmakers
Pharmaceutical Distribution
Pharmaceutical Retail Sector
Company Profile
Abbott Laboratories
Eli Lilly
Demographic Forecast
  Table: Population Headline Indicators (Puerto Rico 1990-2025)
  Table: Key Population Ratios (Puerto Rico 1990-2025)
  Table: Urban/Rural Population & Life Expectancy (Puerto Rico 1990-2025)
  Table: Population By Age Group (Puerto Rico 1990-2025)
  Table: Population By Age Group % (Puerto Rico 1990-2025)
Pharmaceutical Expenditure Forecast Model
Healthcare Expenditure Forecast Model
Notes On Methodology
Risk/Reward Index Methodology
Index Overview
  Table: Pharmaceutical Risk/Reward Index Indicators
Indicator Weightings
Skip to top

Ask Your Question

Puerto Rico Pharmaceuticals and Healthcare Report Q4 2016
Company name*:
Contact person*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: